One clinical study revealed that EGFR expression was elevated in hepatoblastoma specimens56, as a target of the Wnt/β-catenin pathway in liver95, which may explain why our ABC-Myc cell line is sensitive to genetic and pharmacologic inhibition of EGFR. The gene discussed is EGFR; the disease is hepatoblastoma.